Handelsbanken Fonder Ab Abbott Laboratories Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Abbott Laboratories stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 1,692,554 shares of ABT stock, worth $193 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

1,692,554

Previous 1,615,463 4.77%

Holding current value

$193 Million

Previous $168 Million 14.96%

% of portfolio

0.76%

Previous 0.73%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$100.07 - $118.13 $7.71 Million - $9.11 Million	77,091 Added 4.77%	1,692,554 $193 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $36.5 Million - $40.7 Million	-362,321 Reduced 18.32%	1,615,463 $168 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $7.06 Million - $7.8 Million	-64,451 Reduced 3.16%	1,977,784 $225 Million
Q4 2023 Feb 01, 2024	BUY	$90.19 - $110.4 $22.3 Million - $27.3 Million	246,836 Added 13.75%	2,042,235 $225 Million
Q3 2023 Oct 19, 2023	BUY	$95.53 - $114.62 $82,728 - $99,260	866 Added 0.05%	1,795,399 $174 Million
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $2.02 Million - $2.26 Million	-20,082 Reduced 1.11%	1,794,533 $196 Million
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $4.33 Million - $5.09 Million	44,685 Added 2.52%	1,814,615 $184 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $2.37 Million - $2.78 Million	-24,893 Reduced 1.39%	1,769,930 $194 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $7.76 Million - $8.99 Million	80,222 Added 4.68%	1,794,823 $174 Million
Q2 2022 Aug 03, 2022	BUY	$102.07 - $123.37 $6.7 Million - $8.09 Million	65,609 Added 3.98%	1,714,601 $186 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $155,181 - $189,233	-1,361 Reduced 0.08%	1,648,992 $195 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $13.3 Million - $16.3 Million	-115,292 Reduced 6.53%	1,650,353 $232 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $4.81 Million - $5.32 Million	41,217 Added 2.39%	1,765,645 $209 Million
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $3.3 Million - $3.89 Million	-31,200 Reduced 1.78%	1,724,428 $200 Million
Q1 2021 Apr 29, 2021	BUY	$108.84 - $128.23 $21.2 Million - $25 Million	195,152 Added 12.51%	1,755,628 $210 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $221,235 - $241,082	2,107 Added 0.14%	1,560,476 $171 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $8.34 Million - $10.1 Million	90,961 Added 6.2%	1,558,369 $170 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $27.8 Million - $35.6 Million	362,969 Added 32.86%	1,467,408 $134 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $1.98 Million - $2.9 Million	-31,548 Reduced 2.78%	1,104,439 $87.2 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $487,547 - $542,754	6,210 Added 0.55%	1,135,987 $98.7 Million
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $7.82 Million - $8.48 Million	95,600 Added 9.24%	1,129,777 $94.5 Million
Q2 2019 Jul 12, 2019	BUY	$72.88 - $85.0 $6.7 Million - $7.82 Million	92,000 Added 9.76%	1,034,177 $87 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $11.5 Million - $13.9 Million	173,290 Added 22.54%	942,177 $75.3 Million
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $36 Million - $40.8 Million	548,887 Added 249.49%	768,887 $55.6 Million
Q3 2018 Oct 23, 2018	BUY	$60.81 - $73.36 $13.4 Million - $16.1 Million	220,000 New	220,000 $16.1 Million
Q3 2018 Oct 19, 2018	SELL	$60.81 - $73.36 $4.56 Million - $5.5 Million	-75,000 Closed	0 $0
Q2 2018 Jul 11, 2018	BUY	$57.57 - $63.54 $1.15 Million - $1.27 Million	20,000 Added 36.36%	75,000 $4.57 Million
Q1 2018 May 18, 2018	BUY	$56.27 - $63.62 $3.09 Million - $3.5 Million	55,000 New	55,000 $3.3 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Abbott Laboratories Transaction History